Bon Natural Life (BON) Limited announced an exclusive cooperation agreement with Beijing Huahai Keyuan. The term of the agreement is 36 months with a total contract value of 32 million US dollars. Pursuant to the agreement, Beijing Huahai Keyuan will serve as the exclusive sales partner of BON’s postbiotic hypoglycemic ingredients. BON aims to expand into the global blood sugar health market through the development of a series of innovative hypoglycemic solutions.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BON:
- Bon Natural Life to implement 1-for-25 reverse stock split
- Bon Natural Life debuts broccoli-derived sleep wellness line
- Bon Natural Life receives noncompliance notification from Nasdaq
- Bon Natural Life Approves Key Structural Changes at April 2025 Meeting
- Bon Natural Life Secures $12M Apple Polyphenol Supply Agreement